Aspirin Population For MI Prevention Rests On “Floating” Factors – Temple
This article was originally published in The Tan Sheet
Executive Summary
Bayer will have to bolster its evidence that aspirin use has an actual benefit for primary prevention of myocardial infarction, the firm was told during an April 30 FDA feedback meeting